Cite
MLA Citation
Kristen Sweet et al.. “Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial.” Annals of the rheumatic diseases, vol. 78, no. 10, 2019, pp. 1439–1441. http://access.bl.uk/ark:/81055/vdc_100175517232.0x00005a